0001493152-21-029973.txt : 20211129 0001493152-21-029973.hdr.sgml : 20211129 20211129124633 ACCESSION NUMBER: 0001493152-21-029973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211124 FILED AS OF DATE: 20211129 DATE AS OF CHANGE: 20211129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silverman Joshua CENTRAL INDEX KEY: 0001524858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 211454751 MAIL ADDRESS: STREET 1: IROQUOIS CAPITAL MANAGEMENT LLC STREET 2: 205 EAST 42ND ST - 20TH FL. CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0306 4 2021-11-24 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001524858 Silverman Joshua 855 N. WOLFE STREET, SUITE 623 BALTIMORE MD 21205 1 0 0 0 Common Stock 2021-11-24 4 P 0 6734 6.2991 A 80509 D Common Stock 2021-11-24 4 P 0 3266 7.0937 A 83775 D Common Stock 2021-11-26 4 P 0 5000 7.5543 A 88775 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.96, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.17, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.70, inclusive. /s/ Joshua Silverman 2021-11-29